Previously, we identified a novel tumor-suppressive lncRNA, DRAIC (Downregulated RNA in cancer, inhibition of cell invasion and migration), which is a 1.7 kb spliced and polyadenylated RNA that was predominantly expressed in the cytoplasm of prostate cancer cell lines [8]. Here, DRAIC is linked to neoplasm.